Anti-depressant effects of ethanol extract from Cannabis sativa (hemp) seed in chlorpromazine-induced Drosophila melanogaster depression model

References

• Alexander SPH. 2016. Therapeutic potential of cannabis-related drugs. Prog Neuropsychopharmacol Biol Psychiatry. 64:157–166.
   PubMed Web of Science ®Google Scholar
• Anjaneyulu M, Chopra K, Kaur I. 2003. Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. J Med Food. 6(4):391–395.
   PubMedGoogle Scholar
• Appendino G, Chianese G, Taglialatela-Scafati O. 2011. Cannabinoids: occurrence and medicinal chemistry. Curr Med Chem. 18(7):1085–1099.
   PubMed Web of Science ®Google Scholar
• Araujo SM, Bortolotto VC, Poetini MR, Dahleh MMM, Couto SF, Pinheiro FC, Meichtry LB, Musachio EAS, Ramborger BP, Roehrs R, et al. 2021. γ-Oryzanol produces an antidepressant-like effect in a chronic unpredictable mild stress model of depression in Drosophila melanogaster. Stress. 24(3):282–212.
   PubMed Web of Science ®Google Scholar
• Aryal B, Lee Y. 2019. Disease model organism for Parkinson disease: Drosophila melanogaster. BMB Rep. 52(4):250–258.
   PubMed Web of Science ®Google Scholar
• Bellen HJ, Tong C, Tsuda H. 2010. 100 years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future. Nat Rev Neurosci. 11(7):514–522.
   PubMed Web of Science ®Google Scholar
• Bolus H, Crocker K, Boekhoff-Falk G, Chtarbanova S. 2020. Modeling neurodegenerative disorders in Drosophila melanogaster. IJMS. 21(9):3055.
   Google Scholar
• Brennenstuhl H, Jung-Klawitter S, Assmann B, Opladen T. 2019. Inherited disorders of neurotransmitters: classification and practical approaches for diagnosis and treatment. Neuropediatrics. 50(1):2–14.
   PubMed Web of Science ®Google Scholar
• Brenton AG, Godfrey AR. 2010. Accurate mass measurement: terminology and treatment of data. J Am Soc Mass Spectrom. 21(11):1821–1835.
   PubMed Web of Science ®Google Scholar
• Callaway J. 2004. Hempseed as a nutritional resource: an overview. Euphytica. 140(1–2):65–72.
   Web of Science ®Google Scholar
• Campos AC, Fogaca MV, Sonego AB, Guimaraes FS. 2016. Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacol Res. 112:119–127.
   PubMed Web of Science ®Google Scholar
• Cassar M, Issa AR, Riemensperger T, Petitgas C, Rival T, Coulom H, Iché-Torres M, Han KA, Birman S. 2015. A dopamine receptor contributes to paraquat-induced neurotoxicity in Drosophila. Hum Mol Genet. 24(1):197–212.
   PubMed Web of Science ®Google Scholar
• Chandrasekhar Y, Ramya EM, Navya K, Phani Kumar G, Anilakumar KR. 2017. Antidepressant like effects of hydrolysable tannins of Terminalia catappa leaf extract via modulation of hippocampal plasticity and regulation of monoamine neurotransmitters subjected to chronic mild stress (CMS). Biomed Pharmacother. 86:414–425.
   PubMed Web of Science ®Google Scholar
• Chia SJ, Tan EK, Chao YX. 2020. Historical perspective: models of Parkinson's disease. IJMS. 21(7):2464.
   Google Scholar
• Citti C, Linciano P, Panseri S, Vezzalini F, Forni F, Vandelli MA, Cannazza G. 2019. Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry. Front Plant Sci. 10:120.
   PubMed Web of Science ®Google Scholar
• Cowen PJ, Browning M. 2015. What has serotonin to do with depression? World Psychiatry. 14(2):158–160.
   PubMed Web of Science ®Google Scholar
• de Mello Schier AR, de Oliveira Ribeiro NP, Coutinho DS, Machado S, Arias-Carrion O, Crippa JA, Zuardi AW, Nardi AE, Silva AC. 2014. Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa. CNS Neurol Disord Drug Targets. 13(6):953–960.
   PubMed Web of Science ®Google Scholar
• Dean J, Keshavan M. 2017. The neurobiology of depression: an integrated view. Asian J Psychiatr. 27:101–111.
   PubMed Web of Science ®Google Scholar
• Delcourte S, Etievant A, Haddjeri N. 2021. Role of central serotonin and noradrenaline interactions in the antidepressants' action: electrophysiological and neurochemical evidence. Prog Brain Res. 259:7–81.
   PubMed Web of Science ®Google Scholar
• Denno ME, Privman E, Venton BJ. 2015. Analysis of neurotransmitter tissue content of Drosophila melanogaster in different life stages. ACS Chem Neurosci. 6(1):117–123.
   PubMed Web of Science ®Google Scholar
• Dunlop BW, Nemeroff CB. 2007. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 64(3):327–337.
   PubMed Web of Science ®Google Scholar
• El-Alfy AT, Ivey K, Robinson K, Ahmed S, Radwan M, Slade D, Khan I, ElSohly M, Ross S. 2010. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. Pharmacol Biochem Behav. 95(4):434–442.
   PubMed Web of Science ®Google Scholar
• Fakhoury M. 2015. New insights into the neurobiological mechanisms of major depressive disorders. Gen Hosp Psychiatry. 37(2):172–177.
   PubMed Web of Science ®Google Scholar
• Fernandez-Ruiz J, Moreno-Martet M, Rodriguez-Cueto C, Palomo-Garo C, Gomez-Canas M, Valdeolivas S, Guaza C, Romero J, Guzman M, Mechoulam R, et al. 2011. Prospects for cannabinoid therapies in basal ganglia disorders. Br J Pharmacol. 163(7):1365–1378.
   PubMed Web of Science ®Google Scholar
• Harrold MW, Chang YA, Wallace RA, Farooqui T, Wallace LJ, Uretsky N, Miller DD. 1987. Charged analogues of chlorpromazine as dopamine antagonists. J Med Chem. 30(9):1631–1635.
   PubMed Web of Science ®Google Scholar
• Hendricks JC, Finn SM, Panckeri KA, Chavkin J, Williams JA, Sehgal A, Pack AI. 2000. Rest in Drosophila is a sleep-like state. Neuron. 25(1):129–138.
   PubMed Web of Science ®Google Scholar
• Hood S, Amir S. 2017. Neurodegeneration and the circadian clock. Front Aging Neurosci. 9:170.
   Google Scholar
• Jiang MD, Zheng Y, Wang JL, Wang YF. 2017. Drug induces depression-like phenotypes and alters gene expression profiles in Drosophila. Brain Res Bull. 132:222–231.
   PubMed Web of Science ®Google Scholar
• Katz RJ, Roth KA, Carroll BJ. 1981. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev. 5(2):247–251.
   PubMed Web of Science ®Google Scholar
• Kaur K, Simon AF, Chauhan V, Chauhan A. 2015. Effect of bisphenol A on Drosophila melanogaster behavior-a new model for the studies on neurodevelopmental disorders. Behav Brain Res. 284:77–84.
   PubMed Web of Science ®Google Scholar
• Keles B, McCrae N, Grealish A. 2020. A systematic review: the influence of social media on depression, anxiety and psychological distress in adolescents. Int J Adolesc Youth. 25(1):79–93.
   Web of Science ®Google Scholar
• Kim S, Hong KB, Kim S, Suh HJ, Jo K. 2020. Creatine and taurine mixtures alleviate depressive-like behaviour in Drosophila melanogaster and mice via regulating Akt and ERK/BDNF pathways. Sci Rep. 10(1):11370.
   PubMed Web of Science ®Google Scholar
• Ko CH, Koon CM, Yu SL, Lee KY, Lau CBS, Chan EHY, Wing YK, Fung KP, Leung PC. 2016. Hypnotic effects of a novel anti-insomnia formula on Drosophila insomnia model. Chin J Integr Med. 22(5):335–343.
   PubMed Web of Science ®Google Scholar
• Kobayashi K. 2001. Role of catecholamine signaling in brain and nervous system functions: new insights from mouse molecular genetic study. J Investig Dermatol Symp Proc. 6(1):115–121.
   PubMedGoogle Scholar
• Krishnan V, Nestler EJ. 2011. Animal models of depression: molecular perspectives. Curr Top Behav Neurosci. 7:121–147.
   PubMedGoogle Scholar
• Kulkarni SK, Bhutani MK, Bishnoi M. 2008. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology. 201(3):435–442.
   PubMed Web of Science ®Google Scholar
• Kumar A, Sharma B, 2020. Phytochemicals as antidepressants. In: Patra JK, Shukla AC, Das G, editors. Advances in pharmaceutical biotechnology. New York (NY): Springer; p. 115–131.
   Google Scholar
• Kurkin V, Dubishchev A, Ezhkov V, Titova I, Avdeeva E. 2006. Antidepressant activity of some phytopharmaceuticals and phenylpropanoids. Pharm Chem J. 40(11):614–619.
   Google Scholar
• Kwon S, Lee B, Kim M, Lee H, Park HJ, Hahm DH. 2010. Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry. 34(2):265–270.
   PubMed Web of Science ®Google Scholar
• Lachenmeier DW, Walch SG. 2005. Analysis and toxicological evaluation of cannabinoids in hemp food products–a review. Elec J Env Agric Food Chem. 4:812–826.
   Google Scholar
• Lavergne F, Jay TM. 2010. A new strategy for antidepressant prescription. Front Neurosci. 4:192.
   PubMed Web of Science ®Google Scholar
• Lee SH, Min KJ. 2015. Life-extending effect of phytochemicals in Drosophila. In: Vaiserman AM, Moskalev AA, Pasyukova EG, editors. Life extension. New York (NY): Springer; p. 229–244.
   Google Scholar
• Ligresti A, De Petrocellis L, Di Marzo V. 2016. From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology. Physiol Rev. 96(4):1593–1659.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Mandrioli M, Tura M, Scotti S, Toschi TG. 2019. Fast detection of 10 cannabinoids by RP-HPLC-UV method in Cannabis sativa L. Molecules. 24(11):2113.
   PubMed Web of Science ®Google Scholar
• Manji HK, Drevets WC, Charney DS. 2001. The cellular neurobiology of depression. Nat Med. 7(5):541–547.
   PubMed Web of Science ®Google Scholar
• Martin CA, Krantz DE. 2014. Drosophila melanogaster as a genetic model system to study neurotransmitter transporters. Neurochem Int. 73:71–88.
   PubMed Web of Science ®Google Scholar
• Messina F, Rosati O, Curini M, Marcotullio MC. 2015. Cannabis and bioactive cannabinoids: Studies in natural products chemistry. In: Atta U, editor. Studies in natural products chemistry. Oxford: Elsevier; p. 17–57.
   Google Scholar
• Mori A, Ohashi S, Nakai M, Moriizumi T, Mitsumoto Y. 2005. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice. Neurosci Res. 51(3):265–274.
   PubMed Web of Science ®Google Scholar
• Moraga-Amaro R, Gonzalez H, Pacheco R, Stehberg J. 2014. Dopamine receptor D3 deficiency results in chronic depression and anxiety. Behav Brain Res. 274:186–193.
   Google Scholar
• Nathan PJ. 2001. Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology. J Psychopharmacol. 15(1):47–54.
   PubMed Web of Science ®Google Scholar
• Noldner M, Schotz K. 2002. Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med. 68:577–580.
   PubMed Web of Science ®Google Scholar
• O'Kane CJ. 2011. Drosophila as a model organism for the study of neuropsychiatric disorders. Curr Top Behav Neurosci. 7:37–60.
   PubMedGoogle Scholar
• Pathak L, Agrawal Y, Dhir A. 2013. Natural polyphenols in the management of major depression. Expert Opin Investig Drugs. 22(7):863–880.
   PubMed Web of Science ®Google Scholar
• Resstel LB, Joca SR, Moreira FA, Correa FM, Guimaraes FS. 2006. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. Behav Brain Res. 172(2):294–298.
   PubMed Web of Science ®Google Scholar
• Reus GZ, Stringari RB, Ribeiro KF, Luft T, Abelaira HM, Fries GR, Aguiar BW, Kapczinski F, Hallak JE, Zuardi AW, et al. 2011. Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala. Acta Neuropsychiatr. 23(5):241–248.
   PubMed Web of Science ®Google Scholar
• Ries AS, Hermanns T, Poeck B, Strauss R. 2017. Serotonin modulates a depression-like state in Drosophila responsive to lithium treatment. Nat Commun. 8(1):1–11.
   PubMedGoogle Scholar
• Russo EB. 2007. History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers. 4(8):1614–1648.
   PubMed Web of Science ®Google Scholar
• Sarchiapone M, Carli V, Camardese G, Cuomo C, Di Giuda D, Calcagni ML, Focacci C, De Risio S. 2006. Dopamine transporter binding in depressed patients with anhedonia. Psychiatry Res. 147(2–3):243–248.
   PubMed Web of Science ®Google Scholar
• Shohat-Ophir G, Kaun KR, Azanchi R, Mohammed H, Heberlein U. 2012. Sexual deprivation increases ethanol intake in Drosophila. Science. 335(6074):1351–1355.
   PubMed Web of Science ®Google Scholar
• Shukla AK, Pragya P, Chaouhan HS, Patel DK, Abdin MZ, Kar Chowdhuri D. 2014. Mutation in Drosophila methuselah resists paraquat induced Parkinson-like phenotypes. Neurobiol Aging. 35(10):2419.e1–2419.e6.
   PubMed Web of Science ®Google Scholar
• Silote GP, Sartim A, Sales A, Eskelund A, Guimarães FS, Wegener G, Joca S. 2019. Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms. J Chem Neuroanat. 98:104–116.
   PubMed Web of Science ®Google Scholar
• Thanacoody R. 2020. Antidepressant and antipsychotic poisoning. Medicine. 48(3):194–196.
   Google Scholar
• United Nations Office on Drug and Crime. 2009. Recommended methods for the identification and analysis of Cannabis and Cannabis products: manual for use by national drug testing laboratories. New York (NY): United Nations Publications; p. 1–50.
   Google Scholar
• Vadnie CA, McClung CA. 2017. Circadian rhythm disturbances in mood disorders: insights into the role of the suprachiasmatic nucleus. Neural Plast. 2017:1504507.
   PubMed Web of Science ®Google Scholar
• Venzala E, Garcia-Garcia AL, Elizalde N, Tordera RM. 2013. Social vs. environmental stress models of depression from a behavioural and neurochemical approach. Eur Neuropsychopharmacol. 23(7):697–708.
   PubMed Web of Science ®Google Scholar
• Weston-Green K. 2018. The united chemicals of cannabis: Beneficial effects of cannabis phytochemicals on the brain and cognition. In: Costain W, Lapraire RB, editors. Recent advances in cannabinoid research. Ukraine: InTechOpen; p. 1–19.
   Google Scholar
• Willner P. 1990. Animal models of depression: an overview. Pharmacol Therapeut. 45(3):425–455.
   PubMed Web of Science ®Google Scholar
• Xu Y, Li S, Chen R, Li G, Barish PA, You W, Chen L, Lin M, Ku B, Pan J, et al. 2010. Antidepressant-like effect of low molecular proanthocyanidin in mice: involvement of monoaminergic system. Pharmacol Biochem Behav. 94(3):447–453.
   PubMed Web of Science ®Google Scholar
• Yang Z, Bertolucci F, Wolf R, Heisenberg M. 2013. Flies cope with uncontrollable stress by learned helplessness. Curr Biol. 23(9):799–803.
   PubMed Web of Science ®Google Scholar
• Zanelati TV, Biojone C, Moreira FA, Guimarães FS, Joca SR. 2010. Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br J Pharmacol. 159(1):122–128.
   Google Scholar
• Zhu X, Li W, Li Y, Xu W, Yuan Y, Zheng V, Zhang H, O'Donnell JM, Xu Y, Yin X. 2019. The antidepressant- and anxiolytic-like effects of resveratrol: involvement of phosphodiesterase-4D inhibition. Neuropharmacology. 153:20–31.
   PubMed Web of Science ®Google Scholar
• Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimaraes FS. 2006. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res. 39(4):421–429.
   PubMed Web of Science ®Google Scholar
• Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG. 1982. Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacology. 76(3):245–250.
   PubMed Web of Science ®Google Scholar